Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2 - PubMed (original) (raw)
. 1992 Dec 1;149(11):3580-7.
Affiliations
- PMID: 1331239
Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2
K C Parker et al. J Immunol. 1992.
Abstract
Previous studies have indicated that most HLA-A2-binding peptides are 9 amino acid (aa) residues long, with a Leu at position 2 (P2), and a Val or Leu at P9. We compared the binding properties of different peptides by measuring the rate of dissociation of beta 2-microglobulin from peptide-specific HLA-A2 complexes. The simplest peptide that we identified that could form HLA-A2 complexes had the sequence (in single letter aa code) GLFGGGGGV, indicating that three nonglycine aa are sufficient for binding to HLA-A2. To determine whether most nonapeptides that contained Leu at P2 and Val or Leu at P9 could bind to HLA-A2, we tested the binding of nonapeptides selected from published HIV and melanoma protein sequences, and found that six of seven tested formed stable HLA-A2 complexes. We identified an optimal antigenic undecapeptide from the cytomegalovirus gB protein that could form stable HLA-A2 complexes that contained apparent anchor residues at P2 and P11 (sequence FIAGN-SAYEYV), indicating that the spacing between anchor residues can be somewhat variable. Finally, we tested the importance of every aa in the influenza A matrix peptide 58-66 (sequence GILGFVFTL) for binding to HLA-A2, by using Ala-substituted and Lys-substituted peptides. We found that multiple positions were important for stable binding, including P2, P3, P5-P7, and P9. We conclude that the P2 and P9 anchor residues are of prime importance for peptide binding to HLA-A2. However, other peptide side chains (especially at P3) contribute to the stability of the interaction. In certain cases, the optimal length for peptide binding can be longer than 9 residues.
Similar articles
- Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8.
DiBrino M, Parker KC, Shiloach J, Turner RV, Tsuchida T, Garfield M, Biddison WE, Coligan JE. DiBrino M, et al. J Immunol. 1994 Jan 15;152(2):620-31. J Immunol. 1994. PMID: 7506728 - Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2.
Guichard G, Connan F, Graff R, Ostankovitch M, Muller S, Guillet JG, Choppin J, Briand JP. Guichard G, et al. J Med Chem. 1996 May 10;39(10):2030-9. doi: 10.1021/jm9509511. J Med Chem. 1996. PMID: 8642561 - Class I MHC-peptide interaction: structural and functional aspects.
Ruppert J, Kubo RT, Sidney J, Grey HM, Sette A. Ruppert J, et al. Behring Inst Mitt. 1994 Jul;(94):48-60. Behring Inst Mitt. 1994. PMID: 7998914 Review. - Peptide binding to MHC class I molecules: implications for antigenic peptide prediction.
Parker KC, Shields M, DiBrino M, Brooks A, Coligan JE. Parker KC, et al. Immunol Res. 1995;14(1):34-57. doi: 10.1007/BF02918496. Immunol Res. 1995. PMID: 7561340 Review.
Cited by
- Thioamide Analogues of MHC I Antigen Peptides.
Gibadullin R, Morris RK, Niu J, Sidney J, Sette A, Gellman SH. Gibadullin R, et al. J Am Chem Soc. 2023 Nov 29;145(47):25559-25569. doi: 10.1021/jacs.3c05300. Epub 2023 Nov 15. J Am Chem Soc. 2023. PMID: 37968794 - Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8+ T Cell Responses.
Cho E, Han S, Eom HS, Lee SJ, Han C, Singh R, Kim SH, Park BM, Kim BG, Kim YH, Kwon BS, Nam KT, Choi BK. Cho E, et al. Int J Mol Sci. 2023 Sep 5;24(18):13672. doi: 10.3390/ijms241813672. Int J Mol Sci. 2023. PMID: 37761976 Free PMC article. - Molecular mimicry and cancer vaccine development.
Tagliamonte M, Cavalluzzo B, Mauriello A, Ragone C, Buonaguro FM, Tornesello ML, Buonaguro L. Tagliamonte M, et al. Mol Cancer. 2023 Apr 26;22(1):75. doi: 10.1186/s12943-023-01776-0. Mol Cancer. 2023. PMID: 37101139 Free PMC article. Review. - Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy.
Baleeiro RB, Dunmall LSC, Liu P, Lu S, Lone Y, Lemoine NR, Wang Y. Baleeiro RB, et al. Front Immunol. 2022 May 26;13:902709. doi: 10.3389/fimmu.2022.902709. eCollection 2022. Front Immunol. 2022. PMID: 35720289 Free PMC article. - Opening opportunities for Kd determination and screening of MHC peptide complexes.
Kopicki JD, Saikia A, Niebling S, Günther C, Anjanappa R, Garcia-Alai M, Springer S, Uetrecht C. Kopicki JD, et al. Commun Biol. 2022 May 23;5(1):488. doi: 10.1038/s42003-022-03366-0. Commun Biol. 2022. PMID: 35606511 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous